German Cancer Aid was founded in 1974 and follows the theme “Help. Research. Information.”. We support research projects to improve the prevention, diagnosis, therapy, after-care and self-help of cancer. All supported projects are of the highest scientific quality and have the potential for significant clinical impact, so that cancer patients rapidly benefit from new knowledge. We also invest in the training of future generations of scientists and medical doctors.

German Cancer Aid has grown to be an established player in the national health service and is the most important private source of funds for cancer research in Germany, with an annual investment of about 35 million Euro each year in various research projects. As a consequence of the enormous amount of scientific work in recent decades, the care for cancer patients has fundamentally improved.For more than 40 years, German Cancer Aid has been an important consultant for health and research politics. It makes a significant contribution to the improvement in the care of cancer patients throughout Germany and helps to ensure that the votes of cancer patients are born in mind.German Cancer Aid is exclusively funded from donations and financial contributions from the public. No government funds are employed. Please find further information about our activities on our website or contact us via e-mail: 1977 the Dr. Mildred Scheel Foundation for Cancer Research has sponsored key international meetings focused on current topics in cancer research.
The 8th Mildred Scheel Cancer Conference will take place on June 14-16, 2017 in the
Maritim Hotel Bonn
Kurt-Georg-Kiesinger-Allee 1
53175 Bonn
Phone: +49 (0) 228 8108-0
Fax: +49 (0) 228 8108-811
room-Reservation: +49 (0) 228 8108-777

We would be very pleased if you could participate in this meeting to learn the groundbreaking achievements in cancer research from internationally leading experts, and discuss your research area and the new future perspectives of your field.   



June 14th - 16th, 2017

Maritim Hotel Bonn,